GlassScriptPhysician profile
Sushma Kaul
NPI 1952317091
$6,048.29
in general payments reported to CMS, 2019-2025
33 companies · $951 in 2025
The $951 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $537 · 2021: $499 · 2022: $1,021 · 2023: $912 · 2024: $1,630 · 2025: $951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,315 · Education: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,315.40 |
| Education | $177.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,593.89 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $1,267.71 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $412.61 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $403.65 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Regeneron Healthcare Solutions, INC. | $305.36 | 2019-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $251.22 | 2023-2025 | Uptravi, Opsumit |
| United Therapeutics Corporation | $209.89 | 2022-2024 | Tyvaso |
| Novartis Pharmaceuticals Corporation | $191.97 | 2019-2024 | |
| Electromed, INC. | $182.51 | 2024-2025 | Smartvest |
| Philips North America LLC | $150.52 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Boston Scientific Corporation | $144.89 | 2024 | |
| Phathom Pharmaceuticals, INC. | $105.42 | 2024 | Voquezna |
| Amgen INC. | $85.99 | 2024-2025 | Tezspire |
| Paratek Pharmaceuticals, INC. | $82.13 | 2024 | Nuzyra |
| Insmed, INC. | $77.34 | 2022-2025 | Arikayce |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $76.85 | 2019-2021 | |
| Verona Pharma, INC. | $68.99 | 2025 | Ohtuvayre |
| Pfizer INC. | $67.56 | 2023-2025 | |
| Mylan Specialty L.P. | $49.72 | 2019-2022 | |
| Shionogi INC | $39.06 | 2024-2025 | Fetroja |
| Pulmonx Corporation | $38.92 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Mallinckrodt Enterprises LLC | $33.88 | 2019 | |
| Astellas Pharma US INC | $29.93 | 2024 | Cresemba |
| Ambu INC. | $25.43 | 2024 | |
| Inogen, INC. | $24.98 | 2025 | |
| Grifols USA, LLC | $21.33 | 2025 | Prolastin-C Liquid |
| Abiomed | $19.75 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.26 | 2024 | Glassia |
| Genentech USA, INC. | $15.82 | 2019 | |
| Alexion Pharmaceuticals, INC. | $15.43 | 2022 | |
| Sunovion Pharmaceuticals INC. | $13.13 | 2019 | |
| Mallinckrodt Hospital Products INC. | $12.39 | 2020 | |
| Circassia INC. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sushma Kaul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.